Prudo-Chlebosz Raymond
Insider CIK 1653262 · AKTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | A Award | 2026-10-05 | 2026-10-16 | 3,240 | $7.90 | $25.6K | 76,861 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-08-18 | 2026-10-16 | 9,072 | $7.90 | $71.7K | 73,621 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | $0.40 | $247.5K | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 386,661 | — | $0 | 386,661 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | — | $0 | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 386,661 | $0.40 | $154.7K | 386,661 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 446,428 | $1.12 | $500.0K | 446,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 446,428 | $1.12 | $500.0K | 446,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 446,428 | $1.12 | $500.0K | 2,484,990 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-12-02 | 2024-12-03 | 419,286,000 | — | $0 | 419,286,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-02 | 2024-12-03 | 419,286,000 | — | $0 | 4,077,124,600 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-06-28 | 2024-07-02 | 10,000,000 | — | $0 | 10,000,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-05-31 | 2024-06-04 | 1,326,258,000 | — | $0 | 1,326,258,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-05-31 | 2024-06-04 | 1,326,258,000 | — | $0 | 3,657,838,600 | SEC↗ |